Table 1.
Patient's characteristics of Cohort A.
| Parameters | RCC (n = 88) | HD (n = 10) | P-value | |
|---|---|---|---|---|
| Age at operation, years | Median (Range) | 66 (38–82) | 56 (26–73) | 0.20 |
| BMI, kg/m2 | Median (Range) | 22.6 (14.9–39.2) | 23.9 (18.0–26.6) | 0.73 |
| Sex, n (%) | Male | 63 (71.6) | 6 (60.0) | 0.48 |
| Female | 25 (28.4) | 4 (40.0) | ||
| Histological type, n (%) | Clear cell RCC | 88 (100) | ||
| Pathological T stage, n (%) | T1 | 55 (62.5) | ||
| T2 | 5 (5.7) | |||
| T3 | 28 (31.8) | |||
| Clinical N stage, n (%) | N0 | 87 (98.9) | ||
| N1 | 1 (1.1) | |||
| Clinical M stage, n (%) | M0 | 77 (87.5) | ||
| M1 | 11 (12.5) | |||
| Tumor grade, n (%) | 1–2 | 73 (83.0) | ||
| 3–4 | 15 (17.0) |
Abbreviations: BMI, body mass index; HD, healthy donor; RCC, renal cell carcinoma.